Ember Therapeutics
Ember Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in New York, specializing in the development of regenerative medicines through the application of bone morphogenetic protein-7 (BMP-7). The company aims to address various health conditions, including osteoarthritis, insulin resistance, and organ fibrosis associated with chronic kidney disease and Alport syndrome, as well as metabolic diseases such as obesity and type 2 diabetes. Ember's lead product candidates include MT-006, which has completed a Phase 2a clinical trial for osteoarthritis, and several preclinical candidates targeting chronic kidney disease and metabolic disorders. The company holds approximately 450 patents related to BMP-7 and its derivatives, focusing on innovative formulations and delivery technologies. Ember Therapeutics was founded in 2010 and has positioned itself at the forefront of addressing the rising epidemic of metabolic diseases through its proprietary research in brown fat biology and insulin sensitization.
DermaSilk Brands
Acquisition in 2016
DermaSilk Brands, Inc. is a company based in New Brunswick, New Jersey, that specializes in the manufacture of anti-aging cosmetic products and nutritional supplements. The company offers a diverse range of products designed to address various aspects of aging skin, including facial masks, collagen lifts, wrinkle erase pens, beauty peels, and specialized treatments for the eyes, face, neck, and overall skin health. DermaSilk's product line features innovative solutions such as triple-sculpting creams and airless pump systems, which are available through retail stores. As of 2016, DermaSilk Brands operates as a subsidiary of Ember Therapeutics, Inc.
Migralex
Acquisition in 2016
Migralex is different from most other headache medications. First of all, it has no caffeine. Caffeine is an active ingredient in a variety of over-the-counter and prescription headache drugs. Caffeine does enhance the pain-relieving properties of other medications. However, caffeine is also responsible for causing or worsening headaches in millions of people. Almost everyone who drinks more than one or two cups of coffee a day knows that skipping their usual cup of strong morning coffee can result in a severe headache. The existence of caffeine withdrawal headaches is also well documented in scientific studies. Caffeine also causes or worsens anxiety, depression, insomnia, acid reflux, palpitations, and other problems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.